Slocum, Gordon & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Slocum, Gordon & Co's AMGN Position: Q3 2026 in Review
Slocum, Gordon & Co held its Amgen (AMGN) position steady in Q3 2026 at 562 shares worth $237K. The position accounts for 0.17% of the portfolio, ranked #61.
Slocum, Gordon & Co first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $362K in Q3 2024. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Slocum, Gordon & Co held 562 shares of Amgen worth $237K as of Q3 2026.
- Slocum, Gordon & Co left its Amgen share count unchanged in Q3 2026.
- Amgen made up 0.17% of Slocum, Gordon & Co's portfolio in Q3 2026, its #61 holding.
- Slocum, Gordon & Co first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
- Slocum, Gordon & Co's Amgen position peaked at $362K in Q3 2024.
- 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Slocum, Gordon & Co's 13F filing for Q3 2026, filed 19 Oct 2026.